PreprintCited by 4Cancer Genomics and DiagnosticsGenomics and Rare DiseasesChromatin Remodeling and Cancer

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Oncodrive3D: Fast and accurate detection of structural clusters of somatic mutations under positive selection

Open access
Pellegrini, Stefano, Estrella, Olivia Dove, Muiños, Ferran, Lopez-Bigas, Nuria, Gonzalez-Perez, Abel·2025·Nucleic Acids Research

Preprint — published as 10.1093/nar/gkaf776

Abstract

Identifying the genes capable of driving tumorigenesis in different tissues is one of the central goals of cancer genomics. Computational methods that exploit different signals of positive selection in the pattern of mutations observed in genes across tumors have been developed to this end. One such signal of positive selection is clustering of mutations in areas of the three-dimensional (3D) structure of the protein above the expectation under neutrality. Methods that exploit this signal have been hindered by the paucity in proteins with experimentally solved 3D structures covering their entire sequence. Here, we present Oncodrive3D, a computational method that by exploiting AlphaFold 2 structural models extends the identification of proteins with significant mutational 3D clusters to the entire human proteome. Oncodrive3D shows sensitivity and specificity on par with state-of-the-art cancer driver gene identification methods exploiting mutational clustering, and clearly outperforms them in computational efficiency. We demonstrate, through several examples, how significant mutational 3D clusters identified by Oncodrive3D in different known or potential cancer driver genes can reveal details about the mechanism of tumorigenesis in different cancer types and in clonal hematopoiesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2025.01.11.632354

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 58

  1. 10.1101/gr.134635.111 · DOI
  2. 10.1038/nature12213 · DOI · Paper page
  3. 10.1016/j.cell.2017.09.042 · DOI · Paper page
  4. 10.1093/nar/gks743 · DOI
  5. 2013, OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes, Bioinforma. Oxf. Engl, 29, 2238
  6. 10.1186/s13059-016-0994-0 · DOI
  7. 10.1038/s41588-019-0572-y · DOI
  8. 10.1038/ng.3987 · DOI
  9. 10.1038/s41467-022-34746-z · DOI
  10. 10.1158/0008-5472.CAN-15-3190 · DOI
  11. 10.1093/bioinformatics/btz501 · DOI
  12. 2020, Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer. Nat, Cancer, 1, 122
  13. 10.1126/science.1235122 · DOI · Paper page
  14. 10.1038/srep02650 · DOI
  15. The Cancer Genome Atlas Research Network, Weinstein, J.N. , Collisson, E.A. , Mills, G.B. , Shaw, K.R.M. , Ozenberger, B.A. , Ellrott, K. , Shmulevich, I. , Sander, C. and Stuart, J.M. (2013) The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet., 45, 1113–1120. · DOI · Paper page
  16. Gonzalez-Perez, A. , Perez-Llamas, C. , Deu-Pons, J. , Tamborero, D. , Schroeder, M.P. , Jene-Sanz, A. , Santos, A. and Lopez-Bigas, N . (2013) IntOGen-mutations identifies cancer drivers across tumor types. Nat Meth, advance online publication . · DOI
  17. 10.1038/S41568-020-0290-X · DOI
  18. 10.1016/j.cell.2018.02.060 · DOI · Paper page
  19. 10.1038/s41586-020-1969-6 · DOI · Paper page
  20. 10.1016/j.jmoldx.2014.12.006 · DOI · Paper page
  21. 10.1038/s41586-023-06054-z · DOI
  22. 10.1038/srep26483 · DOI
  23. 10.1038/ng.3586 · DOI
  24. 10.1371/journal.pcbi.1009818 · DOI · Paper page
  25. 10.1038/s41586-021-03771-1 · DOI
  26. 10.1158/2159-8290.CD-17-0321 · DOI
  27. 10.1186/s13073-016-0393-x · DOI
  28. 10.1038/s41467-022-31878-0 · DOI
  29. 10.1038/s41586-019-1689-y · DOI · Paper page
  30. 10.1038/s41588-020-00710-0 · DOI · Paper page
  31. 10.1038/s41586-022-04558-8 · DOI · Paper page
  32. 10.1186/s13059-016-0974-4 · DOI · Paper page
  33. 2021, AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models, Nucleic Acids Res, 50, D439
  34. 10.1093/nar/gkae238 · DOI · Paper page
  35. 10.7554/eLife.82593 · DOI · Paper page
  36. 10.1093/nar/gkad1049 · DOI · Paper page
  37. Xu, H. , Hu, R. and Zhao, Z . (2023) DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons. Mol. Biol. Evol., 40, msad253. · DOI
  38. 10.1093/nar/gkx237 · DOI
  39. 10.1093/nar/gkae241 · DOI
  40. 10.1038/nrc1299 · DOI · Paper page
  41. 10.1038/s41568-018-0060-1 · DOI · Paper page
  42. 10.1200/PO.17.00011 · DOI
  43. 10.1111/j.2517-6161.1995.tb02031.x) · DOI · Paper page
  44. 10.25080/TCWV9851 · DOI · Paper page
  45. 10.1504/..045103 · DOI
  46. OpenVariant: a toolkit to parse and operate multiple input file formats | Bioinformatics | Oxford Academic.
  47. 10.1038/nbt.3820 · DOI · Paper page
  48. 10.1002/pro.4792 · DOI
  49. 10.1200/CCI.20.00108 · DOI
  50. 10.1038/s41586-020-1965-x · DOI
  51. 10.1101/190330 · DOI
  52. 10.1038/s41586-021-03828-1 · DOI · Paper page
  53. Chowdhry, S. , Zhang, Y. , McMahon, M. , Sutherland, C. , Cuadrado, A. and Hayes, J.D. (2013) Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene, 32, 3765–3781. · DOI · Paper page
  54. 10.1016/j.tibs.2023.07.002 · DOI
  55. 10.1093/emboj/19.17.4555 · DOI
  56. 10.1136/jclinpath-2021-207857 · DOI
  57. 10.1038/sj.onc.1208736 · DOI
  58. 10.1056/NEJMp1607591 · DOI · Paper page

Metadata

Authors
Pellegrini, S., Estrella, O. D., Muiños, F., Lopez-Bigas, N., & Gonzalez-Perez, A.
Affiliations
  • Universitat Pompeu Fabra (ES)
  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac, 10, 08028 Barcelona, Spain
Corresponding author
Muiños, Ferran
Venue
Nucleic Acids Research
Publisher
openRxiv
Published
2025-01-14
Volume
53
Issue
15
ISSN
0305-1048 (ISSN-L)
OpenAlex
W4413116127
Cited by
4
References
1
Citations by year
2026: 2 · 2025: 2
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by-nc)
Funders
  • Institute for Research in Biomedicine
  • Fondation Sanofi Espoir
  • Centres de Recerca de Catalunya (501100011033)
  • European Commission (10.13039/501100011033, 13039/501100011033, 501100011033, 101057509, /AEI/10.13039/501100011033)
  • Generalitat de Catalunya (10.13039/501100011033, 501100011033)
  • Ministerio de Economía y Competitividad (13039/501100011033, AEI/ 10.13039/501100011033)
  • Ministerio de Ciencia e Innovación (PRE2021-096986, /AEI/10.13039/ 501100011033)
  • HORIZON EUROPE Framework Programme (HORIZON-HLTH-2021-CARE-05-02, 101057509, PID2021-126568OB-I00)
  • Agencia Estatal de Investigación (AEI//10.13039/501100011033/, 501100011033, 10.13039/501100011033, 13039, .13039/501100011033, 10.13039, AEI/10)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
cancer driver genes, somatic mutations, positive selection, protein structure, carcinogenesis, clonal hematopoiesis, cancer genomics
MeSH terms
Humans, Models, Molecular, Mutation, Neoplasms, Protein Conformation, Selection, Genetic, Software, Cluster Analysis, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review